Medical Equipment

SonarMed™ airway monitoring system Applauded by Frost & Sullivan for Providing Real-time Visualization for Accurate Troubleshooting with Its Endotracheal Tube Airway Monitor

The SonarMed™ system is the first and only FDA-cleared airway monitoring system that provides heightened patient safety, cost savings, and quality measures while lowering average LOS in the NICU. SAN ANTONIO, Dec. 8, 2022 /PRNewswire/ -- Frost & Sullivan recently assessed the neonatal care indus...

2022-12-08 21:00 709

HARRISON.AI NAMED ON THE 2022 CB INSIGHTS' DIGITAL HEALTH 150 LIST

The clinician-led technology platform has been recognized for achievements in computer-aided imaging NEW YORK, Dec. 8, 2022 /PRNewswire/ -- CB Insights today named harrison.ai to its fourth-annualDigital Health 150

2022-12-08 06:00 1230

SmartFuture launches SDK to enable plug-and-play Remote Patient Monitoring in existing healthcare payer and provider applications

SINGAPORE, Dec. 7, 2022 /PRNewswire/ -- SmartFuture, a leading health-tech company and provider of integrated RPM (Remote Patient Monitoring) solutions, has launched anRPM SDK (Software Development Kit) product. SmartFuture's RPM SDK product allows healthcare providers and payers to integrate wh...

2022-12-07 10:36 1546

Veeva Pulse Shows Digitally Enabled Field Teams are Using HCP Time More Effectively in Asia Pacific

HCP Access is selective as nearly half meet with only one company monthly SINGAPORE, Dec. 7, 2022 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced findings from the latestVeeva Pulse Field Trends Report , the largest glob...

2022-12-07 08:00 1352

CORVIA MEDICAL ANNOUNCES RANDOMIZATION OF FIRST PATIENT IN THE RESPONDER-HF CONFIRMATORY TRIAL

Corvia® Atrial Shunt has the potential to change the way heart failure is treated TEWKSBURY, Mass., Dec. 6, 2022 /PRNewswire/ -- Corvia Medical, Inc., a company dedicated to transforming the treatment of heart failure (HF), announced the first patient has been randomized in RESPONDER-HF, a globa...

2022-12-06 20:04 889

BSR KOREA Introduces "Healcerion Co., Ltd." as "2022 Global Procurement Marketer"

SEOUL, South Korea, Dec. 6, 2022 /PRNewswire/ -- As the practitioner of "2022 Global Procurement Marketer (GPM) Project" promoted by the Ministry of SMEs and Startups (MSS) and Korea SMEs and Startups Agency (KOSME), BSR KOREA offered consultation for 40 domestic SMEs that want to enter the inter...

2022-12-06 11:00 1244

BSR KOREA Introduces "CORE VALUE" as "2022 Global Procurement Marketer"

SEOUL, South Korea, Dec. 6, 2022 /PRNewswire/ -- As the practitioner of "2022 Global Procurement Marketer (GPM) Project" promoted by the Ministry of SMEs and Startups (MSS) and Korea SMEs and Startups Agency (KOSME), BSR KOREA offered consultation for 40 domestic SMEs that want to enter the inter...

2022-12-06 11:00 1293

Neeuro and Institute of Mental Health Launch Home-Based Attention Training Programme

SINGAPORE, Dec. 6, 2022 /PRNewswire/ -- Neeuro, a Singapore tech start-up and Agency for Science, Technology and Research (A*STAR) spinoff, and the Institute of Mental Health (IMH) launched Cogo as a complementary home-based attention training programme this month. This solution aims to improve i...

2022-12-06 09:00 1764

Medical Metaverse Company, apoQlar, Receives FDA 510(k) Clearance for its Mixed Reality Surgical Planning Platform, VSI HoloMedicine®

HAMBURG, Germany, Dec. 5, 2022 /PRNewswire/ -- apoQlar, a German medical technology company, today announced it has received FDA 510(k) Class II clearance for VSI HoloMedicine®, a pioneering mixed reality software device enabling surgeons to plan complex procedures using the power of immersive 3D...

2022-12-05 21:00 1514

Program CD47, provided the CMC service by GenScript ProBio to InnobationBio, will further be advanced by the joint venture between Liminatus Pharma LLC and Iris Acquisition Corp

NEW YORK and LONDON, Dec. 5, 2022 /PRNewswire/ -- Recently, Liminatus Pharma LLC ("Liminatus"), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer therapies and Iris Acquisition Corp ("Iris") (Nasdaq: IRAA), a publicly traded special purpose acquisition company ...

2022-12-05 20:00 1041

Epiprotect reduces the cost for treatment of hard to heal leg ulcers with 83%

LINKÖPING, Sweden, Dec. 3, 2022 /PRNewswire/ -- A compilation of data from patients treated at S2Clinic during the period 2019-2022 showed that the cost of treatment of these patients was reduced by approximately 83% compared to conventional treatment. The treatment with Epiprotect also resulted ...

2022-12-03 00:41 2493

Armis Named Clear Leader in SPARK Matrix for Connected Medical Device Security Solutions

Company recognized for comprehensive and robust asset intelligence platform; ranked highest among competitors for technology excellence and customer impact SAN FRANCISCO, Dec. 1, 2022 /PRNewswire/ -- Armis, the leading asset visibility and security company, today announced that it has been named ...

2022-12-01 22:50 1500

S3 Connected Health Receives Frost & Sullivan's Award for Helping Medical Device Companies Create Custom Connected Medical Device Solutions

S3 Connected Health supports its partners and clients by defining optimal solutions that address their unique needs and constraints, taking customers from concept to development, operation, and lifecycle management SAN ANTONIO, Nov. 30, 2022 /PRNewswire/ -- Recently, Frost & Sullivan analyzed th...

2022-11-30 23:59 1116

Prenetics Announces US$20 Million Stock Repurchase Program and Inclusion into the MSCI Global Micro Cap Index

LONDON and HONG KONG, Nov. 30, 2022 /PRNewswire/ -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a global leader in genomic and diagnostic testing, today announced that its board of directors has authorized a share repurchase program, and that it has been included as a c...

2022-11-30 22:15 2130

Cardiac Troponin Diagnostics Market Growth Boosted by High-sensitivity Point-of-care Testing

The rise in emergency department visits due to cardiac complaints drives the demand for cTn biomarkers SAN ANTONIO, Nov. 30, 2022 /PRNewswire/ -- The global demand for cardiac troponin (cTn) diagnostics biomarkers is increasing as more patients with cardiac complaints are visiting emergency depa...

2022-11-30 16:12 901

Etiometry Applauded by Frost & Sullivan for Enabling Timely Decision Support for Critical Care with Its Digital and Automated Solution

The Etiometry Platform elevates clinical staff performance and identifies areas requiring urgent attention for better clinical outcomes, shorter hospital stays, and enhanced revenue opportunities. SAN ANTONIO, Nov. 29, 2022 /PRNewswire/ -- Frost & Sullivan recently assessed the US clinical decis...

2022-11-29 21:00 1623

Venus Medtech to showcase its structural heart treatments at London Valves 2022

The company's growing number of solutions for structural heart disease will be presented at multiple events during the conference betweenNovember 27-29 HANGZHOU, China, Nov. 25, 2022 /PRNewswire/ -- Venus Medtech is building an exciting pipeline of treatments for structural heart disease. The co...

2022-11-25 18:08 6285

XtalPi and CK Life Sciences to collaborate in AI-empowered tumour vaccine research and development, opening a new paradigm for scientific innovation

AI-driven drug research and development (R&D) is breaking new ground, providing faster and more effective treatment options for more patients worldwide HONG KONG and SHENZHEN, China, Nov. 25, 2022 /PRNewswire/ -- XtalPi announced today that they are embarking on a strategic collaboration with CK ...

2022-11-25 09:49 2439

Vieworks exhibits at RSNA 2022 with its complete lineup of next generation x-ray flat panel detectors

ANYANG, South Korea, Nov. 24, 2022 /PRNewswire/ -- Vieworks, a leading digital x-ray imaging solution provider based inSouth Korea, will be exhibiting its complete lineup of DR flat panel detectors (FPD) and dynamic FPDs at RSNA 2022 (South Hall #1723) fromNovember 27th to November 30th.

2022-11-24 10:00 2256

Triastek Receives FDA IND Clearance for 3D Printed Medicine for the Treatment of Ulcerative Colitis

* Triastek's third FDA IND clearance for a 3D printed medicine * T21, a novel potential treatment capable of colon-targeted drug delivery NANJING, China,Nov. 21, 2022 /PRNewswire/ -- Triastek, Inc. ("Triastek") a global healthcare company pioneering 3D printing of pharmaceuticals with its pro...

2022-11-21 21:00 1458
12345 ... 100